KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Shares Repurchased (2016 - 2022)

Biogen has reported Shares Repurchased over the past 14 years, most recently at $250.0 million for Q3 2022.

  • Quarterly results put Shares Repurchased at $250.0 million for Q3 2022, down 66.67% from a year ago — trailing twelve months through Dec 2023 was $250.0 million (down 66.67% YoY), and the annual figure for FY2022 was $750.0 million, down 58.33%.
  • Shares Repurchased for Q3 2022 was $250.0 million at Biogen, down from $500.0 million in the prior quarter.
  • Over the last five years, Shares Repurchased for BIIB hit a ceiling of $2.8 billion in Q2 2018 and a floor of $250.0 million in Q1 2018.
  • Median Shares Repurchased over the past 5 years was $733.9 million (2019), compared with a mean of $1.1 billion.
  • Biggest five-year swings in Shares Repurchased: skyrocketed 251.75% in 2018 and later tumbled 80.89% in 2020.
  • Biogen's Shares Repurchased stood at $1.4 billion in 2018, then skyrocketed by 54.75% to $2.1 billion in 2019, then crashed by 80.89% to $400.0 million in 2020, then skyrocketed by 87.5% to $750.0 million in 2021, then crashed by 66.67% to $250.0 million in 2022.
  • The last three reported values for Shares Repurchased were $250.0 million (Q3 2022), $500.0 million (Q2 2022), and $750.0 million (Q3 2021) per Business Quant data.